Sandercock Colin

Sandercock Colin is listed in filings as SVP at Cue Biopharma, Inc.. This profile follows SEC Form 4 activity through Apr 10, 2026, including 4 public disclosures. Recent filings connect the profile to Cue Biopharma, Inc. (CUE). The current snapshot covers public activity from Mar 25, 2025 to Apr 10, 2026. Reported amounts are shown as $58.0K to $21.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.